The comprehensive mutational and phenotypic spectrum of TUBB8 in female infertility.


Journal

European journal of human genetics : EJHG
ISSN: 1476-5438
Titre abrégé: Eur J Hum Genet
Pays: England
ID NLM: 9302235

Informations de publication

Date de publication:
02 2019
Historique:
received: 20 04 2018
accepted: 18 09 2018
revised: 12 09 2018
pubmed: 10 10 2018
medline: 10 5 2019
entrez: 10 10 2018
Statut: ppublish

Résumé

Human oocyte maturation is a precondition for fertilization and ensuing embryonic development. Previously, we identified TUBB8 variants as a genetic determinant of human oocyte maturation arrest and showed that these variants cause variable and mixed phenotypes in oocyte maturation and early embryo development. We also estimated that rare inherited or de novo variants in the TUBB8 gene accounted for 30% of individuals in a small cohort of patients affected by oocyte maturation arrest. In the present study, we recruited a further 87 patients from unrelated families diagnosed with oocyte maturation or early embryonic arrest and identified 30 patients carrying TUBB8 variants. The corresponding phenotypes not only include oocyte maturation arrest, failure of fertilization, and early embryonic arrest, but also extend to the new phenotype of failure of embryo implantation. These observations provide the most detailed mutational and phenotypic spectrum of TUBB8, further extend the spectrum of variants and dysfunctional oocyte and embryo phenotypes caused by TUBB8 variants, and confirm previous findings for a critical role of TUBB8 during oocyte maturation and early embryonic development. Thus, TUBB8 mutation screening might not only be a genetic diagnostic marker for patients with oocyte maturation arrest, but might also have clinical implications for evaluating the competence of patients' functional oocytes with first polar body (PB1).

Identifiants

pubmed: 30297906
doi: 10.1038/s41431-018-0283-3
pii: 10.1038/s41431-018-0283-3
pmc: PMC6336793
doi:

Substances chimiques

TUBB8 protein, human 0
Tubulin 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

300-307

Références

Nat Rev Mol Cell Biol. 2013 Sep;14(9):549-62
pubmed: 23942453
Bioinformatics. 2015 Aug 15;31(16):2745-7
pubmed: 25851949
Nature. 2016 Aug 17;536(7616):285-91
pubmed: 27535533
N Engl J Med. 2016 Jan 21;374(3):223-32
pubmed: 26789871
Hum Reprod Update. 2015 Jul-Aug;21(4):427-54
pubmed: 25744083
Nat Rev Mol Cell Biol. 2013 Mar;14(3):141-52
pubmed: 23429793
Hum Reprod. 2002 Oct;17(10):2556-9
pubmed: 12351528
Hum Reprod Update. 2017 Nov 1;23(6):706-722
pubmed: 28961822
Hum Reprod. 2001 Oct;16(10):2136-8
pubmed: 11574505
Hum Reprod. 1995 Sep;10(9):2343-9
pubmed: 8530664
PLoS One. 2012;7(10):e46688
pubmed: 23056405
Fertil Steril. 1999 Mar;71(3):567-70
pubmed: 10065801
J Med Genet. 2016 Oct;53(10):662-71
pubmed: 27273344
Fertil Steril. 1990 Aug;54(2):292-6
pubmed: 2379628
Nat Methods. 2010 Apr;7(4):248-9
pubmed: 20354512
Fertil Steril. 2010 Dec;94(7):2507-13
pubmed: 20378111
Hum Reprod. 2017 Feb;32(2):457-464
pubmed: 27989988
Reprod Biomed Online. 2017 Sep;35(3):305-310
pubmed: 28652098

Auteurs

Biaobang Chen (B)

State Key Laboratory of Genetic Engineering, Zhongshan Hospital, Institutes of Biomedical Sciences and School of Life Sciences, Fudan University, Shanghai, 200032, China.

Wenjing Wang (W)

State Key Laboratory of Genetic Engineering, Zhongshan Hospital, Institutes of Biomedical Sciences and School of Life Sciences, Fudan University, Shanghai, 200032, China.

Xiandong Peng (X)

Shanghai Ji Ai Genetics and IVF Institute, Obstetrics and Gynecology Hospital, Fudan University, Shanghai, 200011, China.

Huafeng Jiang (H)

Shanghai Ji Ai Genetics and IVF Institute, Obstetrics and Gynecology Hospital, Fudan University, Shanghai, 200011, China.
Community Health Service Center, 2nd Shimen Road, Jinan District, Shanghai, China.

Shaozhen Zhang (S)

Reproductive Medicine Center, Shanghai Ninth Hospital, Shanghai Jiao Tong University, Shanghai, 200011, China.

Da Li (D)

Department of Obstetrics and Gynecology, Center of Reproductive Medicine, Shengjing Hospital, China Medical University, Shenyang, 110004, China.

Bin Li (B)

Reproductive Medicine Center, Shanghai Ninth Hospital, Shanghai Jiao Tong University, Shanghai, 200011, China.

Jing Fu (J)

Shanghai Ji Ai Genetics and IVF Institute, Obstetrics and Gynecology Hospital, Fudan University, Shanghai, 200011, China.

Yanping Kuang (Y)

Reproductive Medicine Center, Shanghai Ninth Hospital, Shanghai Jiao Tong University, Shanghai, 200011, China.

Xiaoxi Sun (X)

Shanghai Ji Ai Genetics and IVF Institute, Obstetrics and Gynecology Hospital, Fudan University, Shanghai, 200011, China.

Xueqian Wang (X)

State Key Laboratory of Genetic Engineering, Zhongshan Hospital, Institutes of Biomedical Sciences and School of Life Sciences, Fudan University, Shanghai, 200032, China.

Zhihua Zhang (Z)

State Key Laboratory of Genetic Engineering, Zhongshan Hospital, Institutes of Biomedical Sciences and School of Life Sciences, Fudan University, Shanghai, 200032, China.

Ling Wu (L)

Reproductive Medicine Center, Shanghai Ninth Hospital, Shanghai Jiao Tong University, Shanghai, 200011, China.

Zhou Zhou (Z)

State Key Laboratory of Genetic Engineering, Zhongshan Hospital, Institutes of Biomedical Sciences and School of Life Sciences, Fudan University, Shanghai, 200032, China.

Qifeng Lyu (Q)

Reproductive Medicine Center, Shanghai Ninth Hospital, Shanghai Jiao Tong University, Shanghai, 200011, China.

Zheng Yan (Z)

Reproductive Medicine Center, Shanghai Ninth Hospital, Shanghai Jiao Tong University, Shanghai, 200011, China.

Xiaoyan Mao (X)

Reproductive Medicine Center, Shanghai Ninth Hospital, Shanghai Jiao Tong University, Shanghai, 200011, China.

Yao Xu (Y)

State Key Laboratory of Genetic Engineering, Zhongshan Hospital, Institutes of Biomedical Sciences and School of Life Sciences, Fudan University, Shanghai, 200032, China.

Jian Mu (J)

State Key Laboratory of Genetic Engineering, Zhongshan Hospital, Institutes of Biomedical Sciences and School of Life Sciences, Fudan University, Shanghai, 200032, China.

Qiaoli Li (Q)

State Key Laboratory of Genetic Engineering, Zhongshan Hospital, Institutes of Biomedical Sciences and School of Life Sciences, Fudan University, Shanghai, 200032, China.

Li Jin (L)

State Key Laboratory of Genetic Engineering, Zhongshan Hospital, Institutes of Biomedical Sciences and School of Life Sciences, Fudan University, Shanghai, 200032, China.

Lin He (L)

Bio-X Center, Key Laboratory for the Genetics of Developmental and Neuropsychiatric Disorders, Ministry of Education, Shanghai Jiao Tong University, Shanghai, 200030, China.

Qing Sang (Q)

State Key Laboratory of Genetic Engineering, Zhongshan Hospital, Institutes of Biomedical Sciences and School of Life Sciences, Fudan University, Shanghai, 200032, China. sangqing@fudan.edu.cn.

Lei Wang (L)

State Key Laboratory of Genetic Engineering, Zhongshan Hospital, Institutes of Biomedical Sciences and School of Life Sciences, Fudan University, Shanghai, 200032, China. wangleiwanglei@fudan.edu.cn.
Shanghai Center for Women and Children's Health, Shanghai, 200062, China. wangleiwanglei@fudan.edu.cn.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH